Not Yet RecruitingNot Applicable

Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery

4,140 participantsStarted 2021-12

Plain-language summary

This is a multi-center, randomized, controlled trial study to find whether use of chlorhexidine-alcohol or povidone-iodine for pre-vaginal delivery skin prep is superior to reduce postpartum infection in pregnant women with vaginal delivery. The primary outcome is the episiotomy site infection.

Who can participate

Age range19 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with singleton pregnancy * Women who will undergo vaginal delivery after 37+0/7 weeks of gestation Exclusion Criteria: * Women who are allergy to chlorhexidine, alcohol, iodine, or shellfish * Women with any infection at perineum (before vaginal delivery)

What they're measuring

Number of participant with episiotomy site infection

Timeframe: 21 days

Trial details

NCT IDNCT05122169

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Vaginal Delivery trials